跳至主要内容
临床试验/JPRN-UMIN000040190
JPRN-UMIN000040190已完成未知

High flow nasal cannula on sleep apnea syndrome in stroke patients - High flow nasal cannula on sleep apnea syndrome in stroke patients

Tokushima University Hospital0 个研究点目标入组 12 人开始时间: 2020年4月19日最近更新:
适应症

试验速览

阶段
未知
状态
已完成
入组人数
12

研究概览

简要总结

There were no differences in sleep-disordered breathing and sleep quality with and without HFNC therapy as follows: HFNC therapy vs control: apnea-hypopnea index 24.9 vs 21.3/h (p = 0.63), oxygen desaturation index 16.2 vs 12.9/h (p = 0.54), sleep efficiency 80.4 vs 87.1 (p = 0.28), percentage of REM sleep 19.4% vs 27.6% (p = 0.07). Two patients (17%) complained of discomfort among eight patients.

研究设计

研究类型
Observational

入排标准

年龄范围
20years-old 至 ot applicable(—)
性别
All

入选标准

  • 未提供

排除标准

  • SAS with suspected other conditions (neuromuscular disease, heat failure, and narcolepsy), past history of SAS, catecholamine use which may affect the vascular tone, patients having unsuccessful recording in any WatchPat channel.

研究者

相似试验